03 Feb 2019 Capital raise sparks news interest in GPN Vaccines
"New pneumonia jab hope" [Adelaide Advertiser Sunday Mail]...
News
18 Jan 2019 GPN Vaccines raises AUD$1.1M (USD$0.8M)
GPN Vaccines has completed a fully subscribed AUD$1.1 million (USD$0.8 million) capital raising towards development of its proprietary vaccine, Gamma-PN. [Download]...
31 Oct 2018 World Vaccine Congress (Europe)
GPN Vaccines' Chairman & CEO gives presentation on "A new serotype-independent pneumococcal vaccine" at the World Vaccine Congress (Europe) in Lisbon, Portugal...
15 Jun 2018 Patent granted in South Africa
GPN Vaccines’ “Streptococcal Vaccine” patent granted in South Africa....
16 Apr 2018 ISPPD-11 Conference 2018, Melbourne Australia
GPN Vaccines’ Directors and Research team participated in the International Symposium on Pneumococci and Pneumococcal Diseases in Melbourne, Australia....
17 Dec 2017 TECHINSA Awards Early Stage Commercialisation Grant to GPN Vaccines
The South Australian Early Commercialisation Fund administered by TechInSA has awarded GPN Vaccines $300,000....